June 14, 2017
San Francisco-based Omada Health has raised $50 million in new funding, led by commercial partner Cigna. Civilization Ventures and Sanofi Genzyme BioVentures also contributed to the round. Omada last raised money in September 2015, when it took in $48 million. This latest round brings the company’s total funding to $127.5 million.
Along with the funding, Cigna will also expand its collaboration...
October 18, 2016
Mobile clinical trials company Science 37, which connects willing individuals to researchers so they can participate in trials from their homes, has raised $31 million in Series B funding. Previously, the company raised $6.5 million.
The round was led by Redmile Group, with participation from Lux Capital and Sanofi Genzyme BioVentures, the latter of which will also provide Science 37 with...